SY
Syros Pharmaceuticals, Inc.
SYRS · OTC
$0.00 +0.00% (+$0.00)
1M +300.00%
Market Cap $9.39K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 43.12%
Rev. growth 13.01%
FCF growth N/A
Profitability
20 /100
Weak Net margin 1,656.34%
Op. margin 1,298.19%
FCF margin 1,106.87%
Quality
1 /100
Poor ROA 97.86%
Asset turnover 0.06x
ROIC 91.82%
Debt
50 /100
Moderate Current ratio 3.95x
Int. coverage -31.10x
Net debt/EBITDA 0.49x
Stability
42 /100
Moderate Rev. volatility 52.31%
EPS volatility 13.07%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SYRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James E. Bradner
Employees
68
Headquarters
Cambridge
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report